KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $464,635 | -0.2% | 2,558 | +8.0% | 0.02% | -5.3% |
| Q4 2022 | $465,509 | -11.5% | 2,369 | +1.2% | 0.02% | -20.8% |
| Q3 2022 | $526,000 | +111.2% | 2,341 | +18.7% | 0.02% | +118.2% |
| Q2 2022 | $249,000 | +12.7% | 1,972 | +13.3% | 0.01% | +37.5% |
| Q1 2022 | $221,000 | -3.1% | 1,741 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $228,000 | +7.0% | 1,741 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $213,000 | +7.6% | 1,741 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $198,000 | +28.6% | 1,741 | +35.5% | 0.01% | +16.7% |
| Q1 2021 | $154,000 | +10.8% | 1,285 | -6.2% | 0.01% | 0.0% |
| Q4 2020 | $139,000 | +31.1% | 1,370 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $106,000 | -30.7% | 1,370 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $153,000 | +131.8% | 1,370 | +50.5% | 0.01% | +75.0% |
| Q1 2020 | $66,000 | +127.6% | 910 | +139.5% | 0.00% | +300.0% |
| Q4 2019 | $29,000 | +383.3% | 380 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | – | 380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |